Loading…
Reporting person on SEC Form 4
Mark W Kroll
Mark W Kroll is Director at Haemonetics. OQRO lists 2 transactions filed with the SEC under this name, the latest on Jul 28, 2026, each linked to the official Form 4.
Director
Disclosures on record
2
Companies involved
1
Their past purchases, 90 days after disclosure
1 buy, median −25.2% vs S&P 500, beat it 0 of 1 time.
Average −25.2% vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Nov 12, 2025 to Nov 12, 2025, measured from the first close after the filing. Past results, not a forecast.
Disclosure history
HaemoneticsHAE
2 disclosures · Nov 2025 – Jul 2026 · 1 bought
Jul 24, 20262,538disclosed Jul 28
DetailsOfficial recordNov 10, 2025Bought~$99Kdisclosed Nov 12
Details
